株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医療用ウェアラブルの世界市場 ~2025年:バイタルサインモニタリング・血圧モニター・血糖モニター・ECGモニター・パルスオキシメーター

Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025

発行 MarketsandMarkets 商品コード 938894
出版日 ページ情報 英文 163 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。
医療用ウェアラブルの世界市場 ~2025年:バイタルサインモニタリング・血圧モニター・血糖モニター・ECGモニター・パルスオキシメーター Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025
出版日: 2020年05月20日 ページ情報: 英文 163 Pages
担当者のコメント
2020年5月の「医療用ウェアラブルの世界市場」は、主要プレーヤーの企業プロフィールの上、地域別で「マルチパラメータートラッカー 」、「ECG /ホルター/心拍数モニター」、「血圧モニター」等の市場規模数値があります。競合状況の説明も載ってあり、ご興味がありましたらオンラインデモで原本のご案内が可能でございますので、是非ともお申し込み頂ければ幸いでございます。
概要

世界の医療ウェアラブルの市場は予測期間中21.4%のCAGRで推移し、2020年の74億米ドルから、2025年には195億米ドルの規模に成長すると予測されています。スマートフォンの導入の拡大、3G・4Gネットワークの普及、高齢者人口の増加、患者中心のヘルスケア提供への注目の高まりなどの要因が同市場の成長を推進しています。デバイスタイプ別で見ると、2019年においてはバイタルサインモニタリング部門が最大のシェアを占めました。小型でユーザーフレンドリーで、取得データを簡単に表示できる優れたグラフィカルユーザーインターフェースを備えたハイテクデバイスの利用の拡大が同部門の成長を推進しているとみられています。また、製品タイプ別では、パッチ部門が同年最大の市場シェアを占めました。さらに地域別では、同年、北米地域が最大の市場シェアを占めています。スマートフォン、タブレット、その他のモバイルプラットフォームの普及拡大、慢性疾患の蔓延、革新的技術の開発と導入、政府による取り組みの拡大などの要因が同地域の成長を推進しています。

当レポートでは、世界の医療用ウェアラブルの市場を調査し、市場および製品の概要、市場成長への各種影響因子および市場機会の分析、デバイスタイプ・製品・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

938894_4.4 REGIONAL MIX_CLINICAL-GRADE WEARABLES MARKET_FIGURE 16

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題

第6章 産業分析

  • 産業動向
  • 腫瘍学:臨床グレードウェアラブルの次の舞台
  • 臨床グレードウェアラブルの今後の動向
  • 臨床グレードウェアラブルのスタートアップ事業者への投資

第7章 臨床グレードウェアラブル市場の分析・予測:デバイスタイプ別

  • イントロダクション
  • バイタルサインモニタリングデバイス
    • マルチパラメータートラッカー
    • ECG /ホルター/心拍数モニター
    • 血圧モニター
    • パルスオキシメーター
  • グルコースモニタリングデバイス・インスリンポンプ
  • 胎児モニタリング・産科用デバイス
  • 神経モニタリング装置
  • 睡眠モニタリング装置

第8章 臨床グレードウェアラブル市場の分析・予測:製品別

  • イントロダクション
  • パッチ
  • スマートウォッチ
  • アクティビティモニター・リストバンド
  • その他

第9章 臨床グレードウェアラブル市場の分析・予測:エンドユーザー別

  • イントロダクション
  • 長期ケアセンター・介護施設・老人ホーム
  • 病院
  • 外来診療センター
  • 在宅ケア

第10章 臨床グレードウェアラブル市場の分析・予測:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 市場ランキング分析
  • 競合リーダーシップマッピング、2018
  • 競合状況・動向
    • 新製品の発売・機能強化
    • 提携・協力・各種契約
    • 買収

第12章 企業プロファイル

  • KONINKLIJKE PHILIPS N.V.
  • MEDTRONIC PLC
  • OMRON HEALTHCARE CO., LTD. (A PART OF OMRON CORPORATION)
  • BIOTELEMETRY, INC.
  • APPLE, INC.
  • GE HEALTHCARE
  • ABBOTT LABORATORIES
  • DEXCOM, INC.
  • IRHYTHM TECHNOLOGIES, INC.
  • MASIMO CORPORATION
  • PREVENTICE SOLUTIONS, INC.
  • CONTEC MEDICAL SYSTEMS CO. LTD.
  • BIO-BEAT TECHNOLOGIES
  • VITALCONNECT
  • MINTTIHEALTH
  • BIOTRICITY INC.
  • VERILY LIFE SCIENCES (A PART OF ALPHABET INC.)
  • CYRCARDIA ASIA LIMITED
  • TEN3T HEALTHCARE
  • VIVALNK, INC.

第13章 付録

図表

LIST OF TABLES

  • TABLE 1 CLINICAL-GRADE WEARABLES MARKET SNAPSHOT 30
  • TABLE 2 MAJOR INVESTMENTS IN START-UP COMPANIES 47
  • TABLE 3 CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 49
  • TABLE 4 VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 50
  • TABLE 5 VITAL SIGN MONITORING DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 50
  • TABLE 6 MULTIPARAMETER TRACKERS OFFERED BY KEY MARKET PLAYERS 51
  • TABLE 7 MULTIPARAMETER TRACKERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 52
  • TABLE 8 ECG/HOLTER/HEART RATE MONITORS OFFERED BY KEY MARKET PLAYERS 53
  • TABLE 9 ECG/HOLTER/HEART RATE MONITORS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 54
  • TABLE 10 BLOOD PRESSURE MONITORS OFFERED BY KEY MARKET PLAYERS 55
  • TABLE 11 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 55
  • TABLE 12 PULSE OXIMETERS OFFERED BY KEY MARKET PLAYERS 56
  • TABLE 13 PULSE OXIMETERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 57
  • TABLE 14 GLUCOSE MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 58
  • TABLE 15 GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 58
  • TABLE 16 FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY KEY MARKET PLAYERS 59
  • TABLE 17 FETAL MONITORING & OBSTETRIC DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 60
  • TABLE 18 NEUROMONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 61
  • TABLE 19 NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 61
  • TABLE 20 SLEEP MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 62
  • TABLE 21 SLEEP MONITORING DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 63
  • TABLE 22 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 65
  • TABLE 23 CLINICAL-GRADE WEARABLE PATCHES BY KEY MARKET PLAYERS 65
  • TABLE 24 CLINICAL-GRADE WEARABLE PATCHES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 66
  • TABLE 25 CLINICAL-GRADE WEARABLE SMARTWATCHES BY KEY MARKET PLAYERS 67
  • TABLE 26 CLINICAL-GRADE WEARABLE SMARTWATCHES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 68
  • TABLE 27 CLINICAL-GRADE WEARABLE ACTIVITY MONITORS & WRISTBANDS BY KEY MARKET PLAYERS 69
  • TABLE 28 CLINICAL-GRADE WEARABLE ACTIVITY MONITORS & WRISTBANDS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 69
  • TABLE 29 OTHER CLINICAL-GRADE WEARABLES BY KEY MARKET PLAYERS 70
  • TABLE 30 OTHER CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 71
  • TABLE 31 CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 73
  • TABLE 32 CLINICAL-GRADE WEARABLES MARKET FOR LONG-TERM CARE CENTERS, ASSISTED-LIVING FACILITIES, AND NURSING HOMES, BY COUNTRY, 2018-2025 (USD MILLION) 74
  • TABLE 33 CLINICAL-GRADE WEARABLES MARKET FOR HOSPITALS, BY COUNTRY, 2018-2025 (USD MILLION) 75
  • TABLE 34 CLINICAL-GRADE WEARABLES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2025 (USD MILLION) 76
  • TABLE 35 CLINICAL-GRADE WEARABLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018-2025 (USD MILLION) 77
  • TABLE 37 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 81
  • TABLE 38 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 82
  • TABLE 39 NORTH AMERICA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 82
  • TABLE 40 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 82
  • TABLE 41 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 83
  • TABLE 42 US: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 84
  • TABLE 43 US: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 84
  • TABLE 44 US: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 84
  • TABLE 45 US: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 85
  • TABLE 46 US: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 85
  • TABLE 47 CANADA: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 86
  • TABLE 48 CANADA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 87
  • TABLE 49 CANADA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 87
  • TABLE 50 CANADA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 87
  • TABLE 51 CANADA: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 88
  • TABLE 52 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 89
  • TABLE 53 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 89
  • TABLE 54 EUROPE: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 89
  • TABLE 55 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 90
  • TABLE 56 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 90
  • TABLE 57 GERMANY: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 91
  • TABLE 58 GERMANY: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 91
  • TABLE 59 GERMANY: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 92
  • TABLE 60 GERMANY: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 92
  • TABLE 61 GERMANY: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 92
  • TABLE 62 UK: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 93
  • TABLE 63 UK: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 94
  • TABLE 64 UK: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 94
  • TABLE 65 UK: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 94
  • TABLE 66 FRANCE: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 95
  • TABLE 67 FRANCE: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 96
  • TABLE 68 FRANCE: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 96
  • TABLE 69 FRANCE: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 96
  • TABLE 70 FRANCE: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 97
  • TABLE 71 ITALY: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 98
  • TABLE 72 ITALY: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 98
  • TABLE 73 ITALY: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 98
  • TABLE 74 ITALY: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 99
  • TABLE 75 ITALY: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 99
  • TABLE 76 SPAIN: HEALTHCARE IT INITIATIVES 100
  • TABLE 77 SPAIN: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 100
  • TABLE 78 SPAIN: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 101
  • TABLE 79 SPAIN: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 101
  • TABLE 80 SPAIN: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 101
  • TABLE 81 SPAIN: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 102
  • TABLE 82 REST OF EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 102
  • TABLE 83 REST OF EUROPE: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 103
  • TABLE 84 REST OF EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 103
  • TABLE 85 REST OF EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 103
  • TABLE 86 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 106
  • TABLE 87 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 106
  • TABLE 88 ASIA PACIFIC: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 106
  • TABLE 89 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 107
  • TABLE 90 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 107
  • TABLE 91 JAPAN: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 108
  • TABLE 92 JAPAN: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 108
  • TABLE 93 JAPAN: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 108
  • TABLE 94 JAPAN: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 109
  • TABLE 95 JAPAN: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 109
  • TABLE 96 CHINA: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 110
  • TABLE 97 CHINA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 110
  • TABLE 98 CHINA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 111
  • TABLE 99 CHINA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 111
  • TABLE 100 CHINA: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 111
  • TABLE 101 INDIA: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 112
  • TABLE 102 INDIA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 113
  • TABLE 103 INDIA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 113
  • TABLE 104 INDIA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 113
  • TABLE 105 INDIA: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 114
  • TABLE 106 REST OF ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 115
  • TABLE 107 REST OF ASIA PACIFIC: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 115
  • TABLE 108 REST OF ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 115
  • TABLE 109 REST OF ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 116
  • TABLE 110 LATIN AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 116
  • TABLE 111 LATIN AMERICA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 117
  • TABLE 112 LATIN AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 117
  • TABLE 113 LATIN AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 117
  • TABLE 114 MIDDLE EAST & AFRICA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018-2025 (USD MILLION) 118
  • TABLE 115 MIDDLE EAST & AFRICA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION) 119
  • TABLE 116 MIDDLE EAST & AFRICA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 119
  • TABLE 117 MIDDLE EAST & AFRICA: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018-2025 (USD MILLION) 119
  • TABLE 118 PRODUCT LAUNCHES AND ENHANCEMENTS (2019) 124
  • TABLE 119 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2019) 125
  • TABLE 120 ACQUISITIONS (2018 & 2019) 126

LIST OF FIGURES

  • FIGURE 1 CLINICAL-GRADE WEARABLES MARKET SEGMENTATION 20
  • FIGURE 2 RESEARCH DESIGN 22
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 25
  • FIGURE 4 MARKET SIZE APPROACH 1 26
  • FIGURE 5 MARKET SIZE APPROACH 2 27
  • FIGURE 6 TOP-DOWN APPROACH 27
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY 28
  • FIGURE 8 CLINICAL-GRADE WEARABLES BY DEVICE TYPE, 2020 VS. 2025 (USD BILLION) 31
  • FIGURE 9 VITAL SIGNS MONITORING MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 31
  • FIGURE 10 CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2020 VS. 2025 (USD BILLION) 32
  • FIGURE 11 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2020 VS. 2025 (USD BILLION) 33
  • FIGURE 12 CLINICAL-GRADE WEARABLES MARKET: REGIONAL SNAPSHOT 34
  • FIGURE 13 INCREASING GERIATRIC POPULATION AND RISING FOCUS ON PATIENT CENTRIC HEALTHCARE DELIVERY TO DRIVE MARKET GROWTH 35
  • FIGURE 14 PATCHES COMMANDED THE LARGEST SHARE OF THE APAC PRODUCT MARKET IN 2019 36
  • FIGURE 15 MARKET IN JAPAN TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 37
  • FIGURE 16 ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 38
  • FIGURE 17 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD 39
  • FIGURE 18 CLINICAL-GRADE WEARABLES DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
  • FIGURE 19 GEOGRAPHIC SNAPSHOT OF THE CLINICAL-GRADE WEARABLES MARKET 79
  • FIGURE 20 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET SNAPSHOT 81
  • FIGURE 21 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET SNAPSHOT 105
  • FIGURE 22 PRODUCT LAUNCHES-KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2017 TO JANUARY 2020 120
  • FIGURE 23 CLINICAL GRADE WEARABLES MARKET RANKING ANALYSIS, BY PLAYER, 2019 121
  • FIGURE 24 CLINICAL GRADE WEARBLES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2018 123
  • FIGURE 25 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019) 127
  • FIGURE 26 MEDTRONIC PLC: COMPANY SNAPSHOT (2019) 130
  • FIGURE 27 OMRON HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2018) 133
  • FIGURE 28 BIOTELEMETRY, INC.: COMPANY SNAPSHOT (2018) 135
  • FIGURE 29 APPLE, INC.: COMPANY SNAPSHOT (2019) 137  
  • FIGURE 30 GE HEALTHCARE: COMPANY SNAPSHOT (2019) 139
  • FIGURE 31 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 141
  • FIGURE 32 DEXCOM, INC.: COMPANY SNAPSHOT (2018) 143
  • FIGURE 33 IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018) 145
  • FIGURE 34 MASIMO CORPORATION: COMPANY SNAPSHOT (2018) 146
目次
Product Code: MD 7653

"The medical wearables market is expected to grow at a CAGR of 21.4% during the forecast period."

The global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4% during the forecast period of 2020 to 2025. The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population and rising focus on patient-centric healthcare delivery.

"Based on device type, the vital signs monitoring segment accounted for the largest share of the market in 2019."

In 2019, the vital signs monitoring segment accounted for the largest share of the Clinical-Grade market. The large share of this segment can be attributed to the growing use of high-tech devices, which are compact, user-friendly, and come with a better graphical user interface for easy visibility of resulted data are helping to increase the market penetration of clinical-grade wearables. These wearables are playing an integral role in treating and monitoring various medical conditions in patients and driving better health outcomes.

"Based on the product, the patches segment accounted for the largest share of the market in 2019."

In 2019, the patches segment accounted for the largest share of the Clinical-Grade market. The large share of this segment can be attributed to the growth in the adoption of wearable technology is largely dependent on technological advancements and the ease of use. In the past few years, the clinical-grade wearables market has benefited from the growing penetration of 3G and 4G connections across the globe.

"Based on end-user, Long-term care centers, nursing homes, and assisted-living facilities segment is expected to show the highest growth during the forecast period."

The long-term care centers, nursing homes, and assisted-living facilities segment is expected to show the highest growth during the forecast period. The highest growth of this segment can be attributed to the increasing number of people requiring long-term care as a result of the rising geriatric population and the increasing incidence of chronic disorders. Population aging is poised to become one of the most significant social transformations of the twenty-first century, with implications for nearly all sectors of society, including labor and financial markets, the demand for goods and services, such as housing, transportation and social protection, as well as family structures and intergenerational ties.

"By region, North America accounted for the largest market share in 2019." In 2019, North America dominated the clinical-grade wearables market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of North America in the clinical-grade wearables market can be attributed to the high penetration of smartphones, tablets, and other mobile platforms, increasing prevalence of chronic diseases, development & adoption of innovative technologies, and rising government initiatives.

Breakdown of primary participants is as mentioned below:

  • By Company Type: Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
  • By Designation: C-level: 45%, Director-level: 30%, and Others: 25%
  • By Region: North America: 35%, Europe: 30%, Asia Pacific: 25%, Latin America: 5%, and Middle East & Africa: 5%

The prominent players in this market are Medtronic plc (Ireland), Apple, Inc. (US, DexCom Inc. (US), VitalConnect (US), Masimo Corporation (US), Koninklijke Philips N.V. (Netherlands), iRthym Technologies Inc.(US), Omron Corporation (Japan), BioTelemetry, Inc. (US), Bio-beat Technologies (Israel), GE Healthcare (US), Abbott Laboratories (US) and Vivalnk (US).

Research Coverage:

The report analyzes the clinical-grade wearables market and aims at estimating the current size and future growth potential based on various segments, such as product & service and region. It also covers competitive leadership mapping, which helps in analyzing the position of key market companies as visionary leaders, innovators, dynamic players, and emerging players. The report also provides a competitive analysis of the leading players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the clinical-grade wearables market. The report analyzes this market by product & service and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the clinical-grade wearables industry.
  • Market Development: Comprehensive information on the lucrative emerging markets by product & service and region.
  • Market Diversification: Exhaustive information about new testing services, recent developments, and investments in the clinical-grade wearables industry.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, and capabilities of leading players in the clinical-grade wearables market.

TABLE OF CONTENTS

1 INTRODUCTION 18

  • 1.1 OBJECTIVES OF THE STUDY 18
  • 1.2 MARKET DEFINITION 19
    • 1.2.1 MARKETS COVERED 20
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY 20
  • 1.3 CURRENCY 21
  • 1.4 LIMITATIONS 21
  • 1.5 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22

  • 2.1 RESEARCH APPROACH 22
    • 2.1.1 SECONDARY RESEARCH 23
      • 2.1.1.1 Key data from secondary sources 23
    • 2.1.2 PRIMARY RESEARCH 24
      • 2.1.2.1 Key data from primary sources 24
      • 2.1.2.2 Breakdown of primaries 25
  • 2.2 MARKET SIZE ESTIMATION 25
    • 2.2.1 TOP-DOWN APPROACH 26
    • 2.2.2 GROWTH FORECAST 26
  • 2.3 DATA TRIANGULATION APPROACH 28
  • 2.4 MARKET SHARE ESTIMATION 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 35

  • 4.1 CLINICAL-GRADE WEARABLES MARKET OVERVIEW 35
  • 4.2 APAC CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 36
  • 4.3 GEOGRAPHIC SNAPSHOT OF THE CLINICAL-GRADE WEARABLES MARKET 37
  • 4.4 REGIONAL MIX:CLINICAL-GRADE WEARABLES MARKET 38
  • 4.5 CLINICAL-GRADE WEARABLES MARKET: DEVELOPING VS. DEVELOPED MARKETS 39

5 MARKET OVERVIEW 40

  • 5.1 INTRODUCTION 40
  • 5.2 MARKET DYNAMICS 40
    • 5.2.1 DRIVERS 41
      • 5.2.1.1 Increasing awareness of fitness and incidence of lifestyle disorders 41
      • 5.2.1.2 Advent of technologically advanced products 41
      • 5.2.1.3 Growing geriatric population and incidence of chronic diseases 42
      • 5.2.1.4 Cost-containment in healthcare delivery 42
      • 5.2.1.5 Robust penetration of 3G and 4G networks for uninterrupted healthcare services 42
    • 5.2.2 RESTRAINTS 43
      • 5.2.2.1 Unfavorable standards and regulations 43
      • 5.2.2.2 Accuracy, standardization, and analysis of wearable-generated data 43
    • 5.2.3 OPPORTUNITIES 44
      • 5.2.3.1 Growing adoption of mobile platforms 44
      • 5.2.3.2 Increasing adoption of AI and 5G 44
    • 5.2.4 CHALLENGES 44
      • 5.2.4.1 Patent protection of clinical-grade wearables 44
      • 5.2.4.2 Lack of data security and concerns over data theft and healthcare fraud 45
      • 5.2.4.3 Limited battery life 45
      • 5.2.4.4 Device design complexity 45

6 INDUSTRY INSIGHTS 46

  • 6.1 INDUSTRY TRENDS 46
  • 6.2 ONCOLOGY - THE NEXT FRONTIER FOR CLINICAL-GRADE WEARABLES 46
  • 6.3 FUTURE TRENDS IN CLINICAL-GRADE WEARABLES 46
  • 6.4 INVESTMENTS IN CLINICAL-GRADE WEARABLE STARTUPS 47

7 CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 48

  • 7.1 INTRODUCTION 49
  • 7.2 VITAL SIGN MONITORING DEVICES 49
    • 7.2.1 MULTIPARAMETER TRACKERS 51
      • 7.2.1.1 Increase in the prevalence of chronic diseases to drive this market segment 51
    • 7.2.2 ECG/HOLTER/HEART RATE MONITORS 52
      • 7.2.2.1 ECG monitors help improve the quality of care by facilitating the continuous monitoring of patients-a key factor driving market growth 52
    • 7.2.3 BLOOD PRESSURE MONITORS 54
      • 7.2.3.1 Clinical-grade wearable blood pressure monitors form a popular category as these devices are convenient to use and relatively less expensive 54
    • 7.2.4 PULSE OXIMETERS 56
      • 7.2.4.1 Growing adoption of pulse oximeters for self-monitoring purposes to drive growth in this market segment 56
  • 7.3 GLUCOSE MONITORING DEVICES & INSULIN PUMPS 57
    • 7.3.1 GROWTH IN THE NUMBER OF DIABETICS PROPELS THE ADOPTION OF BLOOD GLUCOSE MONITORING DEVICES 57
  • 7.4 FETAL MONITORING & OBSTETRIC DEVICES 59
    • 7.4.1 RISE IN THE NUMBER OF PRETERM BIRTHS TO DRIVE THIS SEGMENT 59
  • 7.5 NEUROMONITORING DEVICES 60
    • 7.5.1 GROWING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE THIS SEGMENT 60
  • 7.6 SLEEP MONITORING DEVICES 62
    • 7.6.1 CONTINUOUS MONITORING OF SLEEP PATTERNS HELPS IDENTIFY THE ROOT CAUSE OF SLEEP-RELATED DISORDERS, THEREBY AIDING PROPER DISEASE MANAGEMENT 62

8 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 64

  • 8.1 INTRODUCTION 65
  • 8.2 PATCHES 65
    • 8.2.1 EASE OF USE, CONVENIENCE, NON-INVASIVENESS, AND COMPACT DESIGN ARE EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT 65
  • 8.3 SMARTWATCHES 67
    • 8.3.1 DATA ACCURACY, LIMITED BATTERY LIFE, AND COMPETITION FROM FITNESS BANDS MAY LIMIT MARKET GROWTH TO A CERTAIN EXTENT 67
  • 8.4 ACTIVITY MONITORS & WRISTBANDS 68
    • 8.4.1 INCREASING PREVALENCE OF CHRONIC DISEASES HAS RESULTED IN A SIGNIFICANT INCREASE IN THE DEMAND FOR ACTIVITY MONITORS 68
  • 8.5 OTHER CLINICAL-GRADE WEARABLES 70

9 CLINICAL-GRADE WEARABLES MARKET, BY END USER 72

  • 9.1 INTRODUCTION 73
  • 9.2 LONG-TERM CARE CENTERS, ASSISTED-LIVING FACILITIES, AND NURSING HOMES 73
    • 9.2.1 INCREASING NUMBER OF PEOPLE REQUIRING LONG-TERM CARE AS A RESULT OF THE RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH 73
  • 9.3 HOSPITALS 74
    • 9.3.1 LEADING HOSPITALS ARE USING WEARABLE TECHNOLOGIES TO TRANSFORM RESIDENT TRAINING AND EMERGENCY MEDICINE COMMUNICATION, WHICH PROVIDES THEM WITH A CRITICAL ADVANTAGE 74
  • 9.4 AMBULATORY CARE CENTERS 75
    • 9.4.1 THE SHIFT OF PATIENT CARE FROM INPATIENT TO OUTPATIENT SETTINGS IS DRIVING THE GROWTH OF THIS END USER SEGMENT 75
  • 9.5 HOME CARE SETTINGS 77
    • 9.5.1 GOVERNMENT INITIATIVES ARE EXPECTED TO SUPPORT THE MARKET GROWTH 77

10 CLINICAL-GRADE WEARABLES MARKET, BY REGION 78

  • 10.1 INTRODUCTION 79
  • 10.2 NORTH AMERICA 80
    • 10.2.1 US 83
      • 10.2.1.1 In 2019, the US accounted for the largest share of the clinical-grade wearables market in North America 83
    • 10.2.2 CANADA 85
      • 10.2.2.1 Need to curtail escalating healthcare costs to drive the market in Canada 85
  • 10.3 EUROPE 88
    • 10.3.1 GERMANY 90
      • 10.3.1.1 Need for better and improved healthcare services will drive the adoption of clinical-grade wearables in Germany 90
    • 10.3.2 UK 93
      • 10.3.2.1 Clinical-grade wearable devices have witnessed high penetration in the UK 93
    • 10.3.3 FRANCE 95
      • 10.3.3.1 Use of telehealth solutions and services through big data to propel market growth 95
    • 10.3.4 ITALY 97
      • 10.3.4.1 Increasing government initiatives for the implementation of eHealth technologies to support market growth 97
    • 10.3.5 SPAIN 99
      • 10.3.5.1 Spain has one of the highest levels of mobile phone penetration in Europe 99
    • 10.3.6 REST OF EUROPE (ROE) 102
  • 10.4 ASIA PACIFIC 104
    • 10.4.1 JAPAN 107
      • 10.4.1.1 Japan is a highly developed market for wireless technologies with a rapidly evolving mobile healthcare sector 107
    • 10.4.2 CHINA 109
      • 10.4.2.1 Growing focus of public & private players on clinical-grade wearables deployment in China to drive market growth 109
    • 10.4.3 INDIA 112
      • 10.4.3.1 Increasing number of initiatives from both government organizations and private players to improve access to healthcare to drive market growth 112
    • 10.4.4 REST OF ASIA PACIFIC 114
  • 10.5 LATIN AMERICA 116
    • 10.5.1 INCREASE IN THE ADOPTION OF MOBILITY SOLUTIONS IN BRAZIL AND MEXICO TO DRIVE GROWTH IN THE CLINICAL-GRADE WEARABLES MARKET 116
  • 10.6 MIDDLE EAST & AFRICA 118
    • 10.6.1 GOVERNMENT INVESTMENTS IN BUILDING A HEALTHCARE MOBILITY FRAMEWORK IN THE MEA REGION TO DRIVE MARKET GROWTH 118

11 COMPETITIVE LANDSCAPE 120

  • 11.1 OVERVIEW 120
  • 11.2 MARKET RANKING ANALYSIS 121
  • 11.3 COMPETITIVE LEADERSHIP MAPPING, 2018 122
    • 11.3.1 VISIONARY LEADERS 122
    • 11.3.2 INNOVATORS 122
    • 11.3.3 EMERGING COMPANIES 122
    • 11.3.4 DYNAMIC DIFFERENTIATORS 122
  • 11.4 COMPETITIVE SITUATION AND TRENDS 124
    • 11.4.1 NEW PRODUCT LAUNCHES & ENHANCEMENTS 124
    • 11.4.2 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 125
    • 11.4.3 ACQUISITIONS 126

12 COMPANY PROFILES 127

(Business overview, Products offered, Recent developments & MnM View)*

  • 12.1 KONINKLIJKE PHILIPS N.V. 127
  • 12.2 MEDTRONIC PLC 130
  • 12.3 OMRON HEALTHCARE CO., LTD. (A PART OF OMRON CORPORATION) 133
  • 12.4 BIOTELEMETRY, INC. 135
  • 12.5 APPLE, INC. 137
  • 12.6 GE HEALTHCARE 139
  • 12.7 ABBOTT LABORATORIES 141
  • 12.8 DEXCOM, INC. 143
  • 12.9 IRHYTHM TECHNOLOGIES, INC. 145
  • 12.10 MASIMO CORPORATION 146
  • 12.11 PREVENTICE SOLUTIONS, INC. 147
  • 12.12 CONTEC MEDICAL SYSTEMS CO. LTD. 148
  • 12.13 BIO-BEAT TECHNOLOGIES 149
  • 12.14 VITALCONNECT 150
  • 12.15 MINTTIHEALTH 151
  • 12.16 BIOTRICITY INC. 152
  • 12.17 VERILY LIFE SCIENCES (A PART OF ALPHABET INC.) 152
  • 12.18 CYRCARDIA ASIA LIMITED 152
  • 12.19 TEN3T HEALTHCARE 153
  • 12.20 VIVALNK, INC. 153

Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

13 APPENDIX 154

  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS 154
  • 13.2 DISCUSSION GUIDE 155
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 159
  • 13.4 RELATED REPORTS 161
  • 13.5 AUTHOR DETAILS 162